Tocilizumab is a humanized monoclonal antibody against interleukin-6 receptor (IL-6R Ab), commonly used as an immunosuppressive in the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis (Table 6, Figure 7). This evidence concerns the gene IL6R and systemic-onset juvenile idiopathic arthritis.